ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Updates

SUB-TYPE: CLASS 3 RECALL

Class 3 recall- Co-Codamol 8/500mg effervescent tablets (Key pharmaceuticals livery

Accord-UK Ltd is recalling a specific batch of Co-Codamol 8/500mg Effervescent Tablets (Key Pharmaceuticals Livery) as a precautionary measure due to the internal tablet blister strips being printed with an incorrect expiry date.

 

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-accord-uk-ltd-co-codamol-8-slash-500mg-effervescent-tablets-key-pharmaceuticals-livery-el-24-a-slash-12?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5bbfbb93-89fc-44d3-8872-098e5dc41b46&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

Alliance do not stock

CO-CODAMOL EFF TAB 8/500MG

Accord (Key livery)

G2301502

 

 

Further Information

 

For medical information enquiries please contact Accord-UK Ltd’s Medical Information Department on 01271 385257, or email medinfo@accord-healthcare.com

For stock control enquiries please contact Accord-UK Ltd’s Customer Services Team on 0800 373573, or email customerservices@accord-healthcare.com

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE:

Early May 2024 bank holiday opening hours

 

To help keep our customers informed of changes to our service, we have published our Early May 2024 bank holiday opening hours for pharmacy and retail customers.

 

Early May 2024 bank holiday opening hours - England, Scotland, Wales and Northern Ireland

 

Early May 2024 bank holiday opening hours - Channel Islands and Isle of Man

SUB-TYPE: CLASS 3 RECALL

Class 3 recall- OPDIVO 10 mg/mL concentrate for solution

Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML)

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-bristol-myers-squibb-pharmaceuticals-limited-opdivo-10-mg-slash-ml-concentrate-for-solution-for-infusion-nivolumab-el-24-a-slash-11

 

Pip code

Product Description

Affected Batches

Alliance do not stock

OPDIVO 10 mg/mL concentrate for solution

8053520

 

 

Further information

For medical information enquiries please contact the Bristol Myers Squibb Medical Information Department by phone (0800 731 1736) or email medical.information@bms.com.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE:

Best Kept Secret: the value of Clinical Homecare to the NHS, patients and society

 

A new independent report commissioned by the NCHA has been released, shining new light on the value of Clinical Homecare. ‘Best Kept Secret: the value of Clinical Homecare to patients, the NHS and society’ has been steered by an independent panel of experts and shines new light on the benefits of homecare to patients, NHS and society.

 

Clinical Homecare can significantly enhance patients’ lives, enabling them to maintain independence, sustain relationships and pursue work or education. Clinical Homecare also provides significant financial savings and benefits to the NHS and wider society. Despite this, Clinical Homecare remains absent from long-term NHS plans, resulting in a significant missed opportunity.

 

Follow this link to read the full report: clinicalhomecare.org/bestkeptsecret

 

Alcura is proud to be a full member of the NCHA, adhering to its stringent Code of Practice and membership criteria. Our commitment to these standards ensures that we provide patients, healthcare professionals and commissioners with the assurance of rigorous excellence in all aspects of Clinical Homecare services we offer.

 

BKS

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use-Freeflex Sodium chloride 0.9%

Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.

 

MHRA drug alert date: 21st March 2024

 

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-fresenius-kabi-limited-sodium-chloride-intravenous-infusion-0-dot-9-percent-freeflex-el-24-a-slash-10

 

Pip code

Product description

Supplier

Batch Numbers

Alliance do not stock

Sodium Chloride Intravenous Infusion 0.9% Freeflex.

Fresenius Kabi

13SMR091
13SMR061
13TAR011
13SLR271

 

 

This is a caution in use only we are not accepting stock returns

 

Further information

For more information or medical information queries please email Medical.Information-UK@fresenius-kabi.com or telephone +44 (0)1928533575

For stock control enquiries please contact FK.complaints-uk@fresenius-kabi.com or telephone +44 (0) 1928 533758

SUB-TYPE: FIELD SAFETY NOTICE

Field safety notice-Carboflex dressings

Field safety notice-Carboflex dressings

We have received a recall from Convatec regarding two sizes of Carboflex dressings

 

Date of recall: 19/03/24

 

PIP CODE

DESCRIPTION

SUPPLIER

AFFECTED BATCH

2527372

CARBOFLEX N/ADH S7661 8X15CM

CONVATEC VIA NWOS

3J02333
3L04810

2527380

CARBOFLEXN/ADH  S7662 15X20CM

CONVATEC LTD (WOUNDCARE)

3J00675
3J02320
3J02332
3L04811
4A00343

 

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE: CLASS 3 RECALL

Class 3 recall- Oestrogel Pump-Pack 750 micrograms/actuation Gel

Besins Healthcare (UK) Ltd has informed the MHRA that a defective pump system was detected in two batches of Oestrogel Pump-Pack 750 micrograms/actuation Gel.

 

 

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-besins-healthcare-uk-ltd-oestrogel-pump-pack-750-micrograms-slash-actuation-gel-estradiol-el-24-a-slash-09?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2a4a39f7-3462-4017-8038-15c956ac6096&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

2171775

OESTROGEL CAN

BESINS HEALTHCARE (ALLFS)

74800

74830

 

 

Further Information

 

For medical information enquiries please contact the Besins Healthcare UK Ltd Medical Information via email besins@eu.propharmagroup.com or by calling +44 (0)1748 828 789.

For stock control enquiries please contact Besins Healthcare UK Ltd Supply Chain via email supplychain-bhuk@besins-healthcare.com.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE:

Alliance Healthcare UK entered into a new wholesale agreement with Opella Healthcare (T/A Sanofi Consumer Healthcare): February 2024

 

We are pleased to announce that, as of 01 February 2024, Alliance Healthcare UK has become one of the chosen wholesalers to supply Opella Healthcare’s (trading as Sanofi Consumer Healthcare) consumer healthcare products to all pharmacies in the United Kingdom.

 

Opella Healthcare’s consumer healthcare portfolio includes the brands Cialis®Together, Allevia®, Buscopan®Dulcolax® and Phenergan®.

 

Click here for full product details.

SUB-TYPE: CLASS 2 RECALL

class 2 recall-Sodiofolin 50 mg/ml, solution for injection/infusion 8ml

medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.

 

 

MHRA drug alert date:12/03/24

 

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-medac-gmbh-t-slash-a-medac-pharma-llp-sodiofolin-50-mg-slash-ml-solution-for-injection-slash-infusion-folinic-acid-400mg-slash-8ml-vial-el-24-a-slash-08?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b4b7a401-8a7a-4596-8818-f021b9fcd1d9&utm_content=immediately)

 

Pip code

Product description

Supplier

Batch Numbers

ALLIANCE DO NOT STOCK

Sodiofolin 50 mg/ml, solution for injection/infusion 8ml

medac GmbH

E230320B

 

 

Further Information

For all medical enquiries, please contact medical information at medac Pharma LLP by email to info@medacpharma.co.uk or by telephone 01786 458086

SUB-TYPE:

Easter bank holiday opening hours 2024

 

To help keep our customers informed of changes to our service, we have published our Easter 2024 bank holiday opening hours for pharmacy and retail customers.

 

Easter 2024 bank holiday opening hours - England, Scotland, Wales and Northern Ireland

 

Easter 2024 bank holiday opening hours - Channel Islands and Isle of Man